We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Show more
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that...
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE...
Growth driven by efficient Avenova® direct-to-consumer e-marketing programs NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care...
Q4 net sales from the eyecare and wound care segment grew 10% over the prior year with higher sales from the Avenova® physician dispensed and OTC channels, and from branded wound care products...
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2023 after market close on Tuesday, March 26...
DERMAdoctor sale reduces operating expenses and bolsters cash NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces a 64% increase in online subscription-based unit sales for its Avenova® Lid & Lash Spray Solution and a 38% increase in...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0244 | -24.4 | 0.1 | 0.1 | 0.065 | 4866725 | 0.08087899 | CS |
4 | -0.0541 | -41.7116422513 | 0.1297 | 0.12985 | 0.065 | 2800865 | 0.09102918 | CS |
12 | -0.0845 | -52.7795128045 | 0.1601 | 0.1879 | 0.065 | 2800283 | 0.13038928 | CS |
26 | -0.2744 | -78.4 | 0.35 | 0.3694 | 0.065 | 2175802 | 0.15173971 | CS |
52 | -1.3044 | -94.5217391304 | 1.38 | 1.52 | 0.065 | 1504218 | 0.30135971 | CS |
156 | -28.3479 | -99.7340229036 | 28.4235 | 30.702 | 0.065 | 1067783 | 7.95641118 | CS |
260 | -34.3014 | -99.7800855223 | 34.377 | 167.3 | 0.065 | 1761931 | 29.82801574 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions